bupropion hydrochloride (xl) (62135-875)

Drug Facts

Product Profile

Brand Name bupropion hydrochloride (xl)

Generic Name bupropion hydrochloride (xl)

Labeler chartwell rx, llc

Dosage Form TABLET, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer

Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-875

Product ID 62135-875_155edd5e-1f89-6a6c-e063-6394a90aacdd

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA208652

Listing Expiration 2026-12-31

Marketing Start 2017-08-21

Pharmacologic Class

Classes

aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135875

Hyphenated Format 62135-875

Supplemental Identifiers

RxCUI

993541 993557

UPC

0362135876302 0362135875305

UNII

ZG7E5POY8O

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (xl) (source: ndc)

Generic Name bupropion hydrochloride (xl) (source: ndc)

Application Number ANDA208652 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

150 mg/1

source: ndc

Packaging

30 TABLET, EXTENDED RELEASE in 1 PACKAGE (62135-875-30)

source: ndc

Packages (1)

62135-875-30 30 TABLET, EXTENDED RELEASE in 1 PACKAGE (62135-875-30)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE (XL) ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "155edd5e-1f89-6a6c-e063-6394a90aacdd", "openfda": {"upc": ["0362135876302", "0362135875305"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["8d9779e7-300e-4720-8ba5-2272b2506cd9"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 PACKAGE (62135-875-30)", "package_ndc": "62135-875-30", "marketing_start_date": "20240328"}], "brand_name": "BUPROPION HYDROCHLORIDE (XL)", "product_id": "62135-875_155edd5e-1f89-6a6c-e063-6394a90aacdd", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "62135-875", "generic_name": "BUPROPION HYDROCHLORIDE (XL)", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE (XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA208652", "marketing_category": "ANDA", "marketing_start_date": "20170821", "listing_expiration_date": "20261231"}